Hla

Journal Title：Hla

HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.

HLA 出版涵盖免疫遗传控制各个方面的全篇原创文章、简讯、评论和综述。范围包括免疫系统分子的功能、生化和遗传研究，包括细胞表面受体及其配体，以及细胞因子和趋化因子、粘附和共刺激分子、抗原受体（如 TcR、NKR、CD1、PAMP、Igs、KIR）以及主要组织相容性复合体（包括经典和非经典 HLA 分子）的基因和产物。论文应描述体外或动物模型中的原创研究，或为反映实体器官或造血干细胞移植、自身免疫、感染性免疫、过敏、肿瘤免疫、疫苗科学、妊娠和疾病易感性等免疫遗传学的临床研究。

Hla创刊于2016年，由Wiley-Blackwell Publishing Ltd出版商出版，收稿方向涵盖Immunology and Microbiology - Immunology全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 ，影响因子指数5.9，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。